Immune aging blueprint offers new clues to fighting cancer
A new study from Monash University has uncovered a genetic blueprint of immune aging, shedding light on why our bodies become less effective at fighting cancer and infections as we grow older. Published in Science Immunology, the preclinical study identified genetic changes that cause aging immune cells to become less effective, helping to explain why older people are more susceptible to cancer…
A new study led by scientists at Monash University has unveiled insights into why the body's effectiveness at combating cancer and infections diminishes with age. The preclinical research, published in Science Immunology, identified unique genetic markers in aging immune cells that cause them to become less efficient over time, making older individuals more susceptible to illness.
The paper, titled "Aging drives distinct chromatin signatures of CD8 T cell dysfunction and the emergence of a unique CD8 Treg cell population," was authored by Daniel Thiele, PhD, a researcher in the lab of Nicole La Gruta, PhD.
"The immune system constantly scans our bodies for potentially cancerous cells and eliminates them, often without us noticing," explained Thiele. "As we age, this natural defense system becomes less effective, leaving us more vulnerable to cancer, infections, and reducing our ability to respond to vaccines." The study offers a blueprint of immune aging, from which potential targets to reverse its decline can be identified.
Focusing on CD8+ T cells, which are crucial for identifying and destroying infected and cancerous cells, the scientists discovered three ways aging disrupts the genetic instructions that control immune cell function. These disruptions affect the cells' ability to adapt to new threats, regulate immune responses, and maintain health.
Additionally, the researchers found a previously unknown group of aging immune cells that lose their protective capabilities and actively suppress the responses of other immune cells, even within the same aging individual. This discovery supports earlier findings from the La Gruta lab, which published a link between the Granzyme K protein and signs of aging in vital organs like the heart, liver, and kidneys in preclinical models.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.